Emesis control by aprepitant in children and adolescents with chemotherapy

[1]  M. Kris,et al.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  N. Seibel,et al.  Aprepitant Use in Children, Adolescents, and Young Adults for the Control of Chemotherapy-Induced Nausea and Vomiting (CINV) , 2010, Journal of pediatric hematology/oncology.

[3]  A. Petrilli,et al.  Aprepitant in adolescent patients for prevention of chemotherapy‐induced nausea and vomiting: A randomized, double‐blind, placebo‐controlled study of efficacy and tolerability , 2009, Pediatric blood & cancer.

[4]  S. Walker,et al.  Stability of an extemporaneous oral liquid aprepitant formulation , 2009, Supportive Care in Cancer.

[5]  P. Dombernowsky,et al.  Anti-emetic therapy in cancer chemotherapy: current status. , 2007, Basic & clinical pharmacology & toxicology.

[6]  H. Schmoll,et al.  Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. , 2007, The oncologist.

[7]  M. Holdsworth,et al.  Acute and delayed nausea and emesis control in pediatric oncology patients , 2006, Cancer.

[8]  Angela R. Smith,et al.  Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescents , 2005, Pediatric Blood & Cancer.

[9]  V. Fanos,et al.  Unlicensed and off‐label uses of drugs in paediatrics: a review of the literature , 2003, Fundamental & clinical pharmacology.

[10]  M. Holdsworth,et al.  Survey ranking of emetogenic control in children receiving chemotherapy. , 2000, Journal of pediatric hematology/oncology.

[11]  D. Osoba,et al.  Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.